Diagnóstico orientado al problema | 03 SEP 03
Alopecia en la mujer
Debido a que la alopecia puede ser un problema de desequilibrio emocional en la mujer, su manejo debe incluir la evaluación de los efectos psicológicos.
Autor: Dra. Thiedke CC. Fuente: Department of Family Medicine at the Medical University of South Carolina, Charleston. EE. UU. Am Fam Physician. 2003 Mar 1;67(5):1007-14.
1. Girman C J, Hartmaier S, Roberts J, Bergfeld W, Waldstreicher J. Patient-perceived importance of negative effects of androgenetic alopecia in women. J Womens Health Gend Based Med 1999;8:1091-5.

2. Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 1993;29:568-75.

3. Paus R, Cotsarelis G. The biology of hair follicle. N Engl J Med 1999;341:491-7.

4. Shapiro J, Wiseman M, Liu H. Practical management of hair loss. Can Fam Physician 2000;46:1469-77.

5. Healey PM, Jacobson EJ. Common medical diagnoses: an algorithmic approach. 3d ed. Philadelphia: Saunders, 2000:208-11.

6. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hardinsky MK, et al. Guidelines of care for androgenetic alopecia. American Academy of Dermatology. J Am Acad Dermatol 1996;35(3 pt 1):465-9.

7. Dawber RR Van Neste D. Alopecia areata. In: Dawber RR. Hair and scalp disorders; common presenting signs, differential diagnosis, and treatment.  Philadelphia: Lippincott, 1995:41-138.

8. Price VH. Treatment of hair loss. N Engl J Med 1999;341:964-73.

9. Tosti A, Piraccini BM. Androgenetic alopecia. Int J Dermatol 1999;38(suppl 1):1-7.

10. Jacobs JR Szpunar CA, Warner ML. Use of topica minoxidil therapy for androgenetic alopecia in women. Int J Dermatol 1993;32:758-62.

11. DeVillez RL, Jacobs JR, Szpunar CA, Warner ML. Androgenetic alopecia in the female, Treatment with 2% topical minoxidil solution. Arch Dermatol                         1994;130:303-7.

12. Scheman A J, West DR Hordinsky MK, Osburn AH,West LE. Alternative formulation for patients with contact reactions to topical 2% and 5% minoxidil vehicle ingredients. Contact Dermatitis 2000;42:241.

13. Bergfeld WE. Retinoids and hair growth. J Am Acad Dermatol 1998;39(2 pt 3):586-9.

14. Sommer M, Wilson C. Therapeutic approaches to the management of common baldness. Int J Clin Pract 1999;53:381-5.

15. Avram MR. Hair transplantation in women. Semin Cutan Med Surg 1999;18:172-6,16.

16. Bertolino AR Alopecia areata. A clinical overview. Postgrad Med 2000; 107(7):81-5,89-90.

17. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549-66.

18. Fiedler-Weiss VC, Buys CM. Evaluation of anthralin in the treatment of alopecia areata. Arch Dermatol 1987;123:1491-3.

19. Sperling LC, Mezebish DS. Hair diseases, Med Clin North Am 1998;82:1155-69.

20. Tosti A, Misciali C, Piraccini BM, Peluso AM, Bardazzi F. Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf 1994;10:310-7.

21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, Washington, D.C.: American Psychiatric Association, 1994:618-21.

22. Keuthen NJ, O'Sullivan RL, Goodchild P, Rodriguez D, Jenike MA, Baer L. Retrospective review of treatment outcome for 63 patients with trichotillomania. Am J Psychiatry 1998;155:560-1,

23. Ninan PT. Rothbaum BO, Marsteller FA, Knight BT,Eccard MB. A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J Clin Psychiatry 2000;61:47-50.


Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí